Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Cash from Operations (2016 - 2025)

Avricore Health has reported Cash from Operations over the past 12 years, most recently at 212601.74 for Q4 2025.

  • Quarterly Cash from Operations fell 185.65% to 212601.74 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 575676.63 through Dec 2025, down 178.42% year-over-year, with the annual reading at 565371.98 for FY2025, 177.05% down from the prior year.
  • Cash from Operations was 212601.74 for Q4 2025 at Avricore Health, up from 221779.9 in the prior quarter.
  • Over five years, Cash from Operations peaked at 301341.0 in Q1 2024 and troughed at 294227.03 in Q2 2025.
  • The 5-year median for Cash from Operations is 4897.42 (2024), against an average of 34079.49.
  • Year-over-year, Cash from Operations skyrocketed 1118.76% in 2023 and then tumbled 3738.54% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 217428.03 in 2021, then skyrocketed by 91.78% to 17881.25 in 2022, then skyrocketed by 1118.76% to 182167.01 in 2023, then soared by 36.26% to 248217.83 in 2024, then plummeted by 185.65% to 212601.74 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Cash from Operations are 212601.74 (Q4 2025), 221779.9 (Q3 2025), and 294227.03 (Q2 2025).